Latest filing published 09 Sept 2026 for Zimmer Biomet Holdings, INC., €254k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Chad F. Phipps on record concern Zimmer Biomet Holdings, Inc., in the capacity of senior executive. In total, 40 filings cover trades dated from 18 March 2016 to 4 September 2026.
No open-market purchase appears, only 10 sales worth €16.4M. The rest of the record consists of 5 share grants and 25 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 9 September 2026 with an open-market sale (€254k) in Zimmer Biomet Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations